Tiepeng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Tiepeng Wang has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
B. Liu
The Second Affiliated Hospital Shaanxi University of Chinese Medicine Xi'an China
1 shared publication- Chunxia Gao
College of Marine Living Resource Sciences and Management, Shanghai Ocean University, Shanghai, 201306, China; Key Laboratory of Sustainable Exploitation of Oceanic Fisheries Resources, Ministry of Education, Shanghai, 201306, China; Key Laboratory of Oceanic Fisheries Exploration, Ministry of Agriculture and Rural Affairs, Shanghai, 201306, China; National Engineering Research Centre for Oceanic Fisheries, Shanghai Ocean University, Shanghai, China
1 shared publication - Fan Shi
Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiao Tong University, Xi’an, China
1 shared publication - Jin Su
Department of Radiation Oncology, The First Affiliated Hospital of Xi’an Jiao Tong University, Xi’an, China
1 shared publication - Jueshuai Wang
School of Economics and Finance, Xi'an Jiaotong University, Xi'an, China
1 shared publication - Jun Ma
Northwest Institute for Nonferrous Metal Research, China
1 shared publication
Latest Publications
- Open Access
- 24 October 2024
- Published by Springer Nature in Molecular Biomedicine
- Vol. 5 (1) , 1-18
Identification of nitric oxide-mediated necroptosis as the predominant death route in Parkinson’s disease
Parkinson's disease (PD) involves multiple forms of neuronal cell death, but the dominant pathway involved in disease progression remains unclear. This study employed RNA sequencing (RNA-seq) of brain tissue to explore gene expression patterns across different stages of PD. Using the Scaden deep learning algorithm, we predicted neurocyte subtypes and modelled dynamic interactions for five classic cell death pathways to identify the predominant routes of neuronal death during PD progression. Our cell type-specific analysis revealed an increasing shift towards necroptosis, which was strongly correlated with nitric oxide synthase (NOS) expression across most neuronal subtypes. In vitro experiments confirmed that nitric oxide (NO) is a key mediator of necroptosis, leading to nuclear shrinkage and decreased mitochondrial membrane potential via phosphorylation of the PIP1/PIP3/MLKL signalling cascade. Importantly, specific necroptosis inhibitors significantly mitigated neuronal damage in both in vitro and in vivo PD models. Further analysis revealed that NO-mediated necroptosis is prevalent in early-onset Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS) and across multiple brain regions but not in brain tumours. Our findings suggest that NO-mediated necroptosis is a critical pathway in PD and other neurodegenerative disorders, providing potential targets for therapeutic intervention.
- 24 October 2024
- Published by Springer Nature in Molecular Biomedicine
- Vol. 5 (1) , 1-18
Open AccessIdentification of nitric oxide-mediated necroptosis as the predominant death route in Parkinson’s disease
Parkinson's disease (PD) involves multiple forms of neuronal cell death, but the dominant pathway involved in disease progression remains unclear. This study employed RNA sequencing (RNA-seq) of brain tissue to explore gene expression patterns across different stages of PD. Using the Scaden deep learning algorithm, we predicted neurocyte subtypes and modelled dynamic interactions for five classic cell death pathways to identify the predominant routes of neuronal death during PD progression. Our cell type-specific analysis revealed an increasing shift towards necroptosis, which was strongly correlated with nitric oxide synthase (NOS) expression across most neuronal subtypes. In vitro experiments confirmed that nitric oxide (NO) is a key mediator of necroptosis, leading to nuclear shrinkage and decreased mitochondrial membrane potential via phosphorylation of the PIP1/PIP3/MLKL signalling cascade. Importantly, specific necroptosis inhibitors significantly mitigated neuronal damage in both in vitro and in vivo PD models. Further analysis revealed that NO-mediated necroptosis is prevalent in early-onset Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS) and across multiple brain regions but not in brain tumours. Our findings suggest that NO-mediated necroptosis is a critical pathway in PD and other neurodegenerative disorders, providing potential targets for therapeutic intervention.
- 1 November 2020
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 108 (3) , e473
Radiation-induced Vaginal Injury After Treatment for Cervical Cancer
- 1 November 2020
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 108 (3) , e473
Radiation-induced Vaginal Injury After Treatment for Cervical Cancer